首页 | 本学科首页   官方微博 | 高级检索  
检索        

加巴喷丁治疗维持性血液透析患者皮肤瘙痒症的临床研究
引用本文:庞家亮,魏崇一,石建华.加巴喷丁治疗维持性血液透析患者皮肤瘙痒症的临床研究[J].中国实用医药,2011,6(21):7-8.
作者姓名:庞家亮  魏崇一  石建华
作者单位:河南省新乡市第一人民医院血液净化中心,453000
摘    要:目的 评价加巴喷丁治疗维持性血液透析(MHD)患者皮肤瘙痒症的疗效及安全性.方法 采用随机对照研究,选择顽固性皮肤瘙痒的MHD患者,随机分为试验组20例和对照组20例.试验组患者每周3次透析后晚间服加巴喷丁100~300 mg,对照组服用安慰剂.4周后根据视觉模拟评分(VAS)进行疗效评价,同时观察不良反应.结果 治疗组得分平均下降(6.0±2.6)分,安慰剂组平均下降(1.3±1.9)分.两组VAS得分下降程度有明显差异(P<0.01).没有患者因药物副作用而中断治疗.结论 加巴喷丁治疗顽固性尿毒症皮肤瘙痒症是安全和有效的.

关 键 词:加巴喷丁  尿毒症瘙痒症  血液透析

Clinical study of Gabapentin in the treatment of uremic pruritus in hemodialysis patients
PANG Jia-liang,WEI Chong-yi,SHI Jian-hua.Clinical study of Gabapentin in the treatment of uremic pruritus in hemodialysis patients[J].China Practical Medical,2011,6(21):7-8.
Authors:PANG Jia-liang  WEI Chong-yi  SHI Jian-hua
Institution:PANG Jia-liang,WEI Chong-yi,SHI Jian-hua.Blood Purification Centre Xinxiang First People's Hospital,Xinxiang city,453000,China
Abstract:Objective To evaluate the safety and efficacy of Gabapentin in treatment of refractory uremic pruritus in maintenance hemodialysis(MHD)patients.Methods A randomized controlled trial was performed.Forty MHD patients with severe pruritus were randomly divided into treatment group(Gabapentin 100-300 rag at dialysis day before sleep)and the placebo group.The efficacy was assessed by visual analogue score after 4-week treatment,and the side effect was also observed to assess the safety.Results The mean decrease ...
Keywords:Gabapentin  Uremic pruritus  Hemodialysis  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号